COVID-19 mortality is associated with pre-existing impaired innate immunity in health conditions.

Lee, Matthew; Chang, Yung; Ahmadinejad, Navid; Johnson-Agbakwu, Crista; Bailey, Celeste; Liu, Li

Lee, Matthew; Chang, Yung; Ahmadinejad, Navid; Johnson-Agbakwu, Crista; Bailey, Celeste; Liu, Li.

Afiliación

Lee M; College of Health Solutions, Arizona State University, Phoenix, AZ, United States.
Chang Y; School of Life Sciences, Arizona State University, Tempe, AZ, United States.
Ahmadinejad N; College of Health Solutions, Arizona State University, Phoenix, AZ, United States.
Johnson-Agbakwu C; Valleywise Health Medical Center, Phoenix, AZ, United States.
Bailey C; Valleywise Health Medical Center, Phoenix, AZ, United States.
Liu L; College of Health Solutions, Arizona State University, Phoenix, AZ, United States.

PeerJ ; 10: e13227, 2022.

Article en En | MEDLINE | ID: mdl-35547187

Asunto(s)

COVID-19; Humanos; COVID-19/genética; Estudios Transversales; Multimorbilidad; Inmunidad Innata/genética; Factores de Riesgo

Palabras clave

COVID-19 mortality; Gene expression; Innate immunity; Molecular risk factor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PeerJ Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google